drugset

drugset / Trial / NCT01188603

Pharmacokinetics of Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder (HSDD)

NCT01188603 ↗

Phase 1 Completed 24 enrolled Sprout Pharmaceuticals, Inc

NaSingle-groupOpen-labelTreatment

Summary

This trial examines the way flibanserin is metabolized in postmenopausal women with Hypoactive Sexual Desire Disorder.

Timeline

Start: 2010-07
Primary completion: 2010-10
Completion: 2010-10

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	flibanserin	Small molecule	100 mg	—

Indications